Omar Z. Yasin

Omar Z. Yasin

Auto-generated profile, based on publicly available information

Omar Z. Yasin

Electrophysiology Section, Division of Cardiology Mayo Clinic Rochester Minnesota USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Experimental Eye Research
Verified
Journal Article
Closed access
YWYao Wang
Yao Wang
TTTu Tran
Tu Tran
KFKevin Firl
Kevin Firl
NHNatalie Huang
Natalie Huang
OYOmar Yasin
Omar Yasin
SMsandra R montezuma
sandra R montezuma

1 February 2025 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
THTatsuhiko Hirao
Tatsuhiko Hirao
MRMaryam E. Rettmann
Maryam E. Rettmann
MSMegan M. Schmidt
Megan M. Schmidt
OYOmar Z. Yasin
Omar Z. Yasin
GKGurukripa N. Kowlgi
Gurukripa N. Kowlgi
KSKonstantinos Siontis
Konstantinos Siontis
BACKGROUND: Power-controlled radiofrequency ablation with irrigated-tip catheters has been the norm for ventricular ablation for almost 2 decades. New catheter technology has recently integrated more accurate tissue temperature sensing enabling temperature-controlled irrigated ablation. We aimed to investigate the in vivo ablation parameters and lesion formation characteristics in ventricular myocardium using a novel temperature-controlled radiofrequency catheter. METHODS: Twenty canines were divided into 3 groups: 4 noninfarcted, acute (phase I); 8 noninfarcted, chronic (phase II); and 8 infarcted, chronic (phase III). Lesions were delivered with a temperature-controlled radiofrequency system utilizing a chemical vapor deposit diamond for efficient thermal diffusivity. In phase I, 17 ablation settings were tested (temperature set points, 50/60/70 °C; ablation duration, 15/30/60/90/120 s; and power limit, 30/50 W). Four and one of these sets of parameters were further tested in phases II and III, respectively. Lesions were assessed by ex vivo contrast-enhanced magnetic resonance imaging and gross pathology 5 weeks after ablation in phases II/III. RESULTS: Across all phases, 111 ablation lesions were delivered. Ablation with the power limit of 50 W, the temperature set point of 60 °C, and the duration of 60 s produced significantly larger and deeper lesions (mean, 569.2 mm 3 ; mean maximal depth, 9.8 mm) compared with 50 W/60 °C/30 s (mean, 340.4 mm 3 ; mean maximal depth, 8.3 mm) and 50 W/50 °C/60 s (mean, 227 mm 3 ; mean maximal depth, 6.9 mm), with P <0.05 for all pairwise comparisons. Ablation of infarcted myocardium in phase III (50 W/60 °C/30 s) resulted in smaller impedance and bipolar electrogram amplitude changes and lesion size compared with ablation in normal myocardium with the same settings. No steam pop, myocardial perforation, or char formation was observed in any of the 111 ablations across all phases. CONCLUSIONS: In vivo radiofrequency ablation in a canine model with a diamond-tip temperature-controlled catheter using a temperature set point of 60 °C and a power limit of 50 W created large lesions without steam pop risk in both normal and infarcted ventricular myocardia.

11 July 2021
Verified
Preprint
Open access
PDF file
OYOmar Yasin
Omar Yasin
JBJaime Bush
Jaime Bush
VVVaibhav Vaidya
Vaibhav Vaidya
JTJason Tri
Jason Tri
MZMartin van Zyl
Martin van Zyl
YCYong-Mei Cha
Yong-Mei Cha
Title: Activation Pattern During His-Bundle PacingOmar Yasin MD, MS1, Jamie Bush BS2, Vaibhav Vaidya MBBS1, Jason Tri1, Martin van Zyl, MBBCh1, Peilin Xiao PhD3, Jie Han MD, PhD4, Cory Scheuermann3, Samuel J. Asirvatham, MD1,5, Yong-Mei Cha, M.D1Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USABoston Scientific Corporation, Washington DC, USAThe Second Affiliated Hospital of Chongqing Medical University, Chongqing ChinaThe First Affiliated Hospital of Zhejiang University, Hangzhou, ChinaDepartment of Pediatrics and Adolescent Medicine, Mayo clinic, Rochester, MN, USAFunding: NoneDisclosures: NoneCorresponding AuthorYong-Mei Cha, MD, FHRSDepartment of Cardiovascular Diseases, Mayo Clinic200 1st ST SWRochester, MN 55901Email:ycha@mayo.edu

1 August 2021 in Heart Rhythm
Verified
Journal Article
Closed access
KIKimitake Imamura
Kimitake Imamura
JDJannis Dickow
Jannis Dickow
ADAmanda J. Deisher
Amanda J. Deisher
MRMaryam Rettmann
Maryam Rettmann
OYOmar Z. Yasin
Omar Z. Yasin
DPDouglas L. Packer
Douglas L. Packer

23 September 2021 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
PDF file
AAAmin Al‐Ahmad
Amin Al‐Ahmad
BKBradley Knight
Bradley Knight
WTWendy Tzou
Wendy Tzou
RSRobert Schaller
Robert Schaller
OYOmar Yasin
Omar Yasin
ANAndrea Natale
Andrea Natale
Background: Intracardiac electrogram data remain one of the primary diagnostic inputs guiding complex ablation procedures. However, the technology to collect, process, and display intracardiac signals has known shortcomings and has not advanced in several decades.Objective: The purpose of this study was to evaluate a new signal processing platform, the PURE EP™ system (PURE), in a multi‐center, prospective study.Methods: Intracardiac signal data of clinical interest were collected from 51 patients undergoing ablation procedures with PURE, the signal recording system, and the 3D mapping system at the same time stamps. The samples were randomized and subjected to blinded, controlled evaluation by three independent electrophysiologists to determine the overall quality and clinical utility of PURE signals when compared to conventional sources. Each reviewer assessed the same (92) signal sample sets and responded to (235) questions using a 10‐point rating scale. If two or more reviewers rated the PURE signal higher than the control, it was deemed superior.Results: A total of 93% of question responses showed consensus amongst the blinded reviewers. Based on the ratings for each pair of signals, a cumulative total of 164 PURE signals out of 218 (75.2%) were statistically rated as Superior for this data set (p < .001). Only 14 PURE signals out of 218 were rated as Inferior (6.4%).Conclusion: The PURE intracardiac signals were statistically rated as superior when compared to conventional systems.

18 May 2023 in Heart Rhythm
Verified
Journal Article
Open access
THTatsuhiko Hirao
Tatsuhiko Hirao
OYOmar Z. Yasin
Omar Z. Yasin
MSMegan Schmidt
Megan Schmidt
NONaoto Otsuka
Naoto Otsuka
MRMaryam Rettmann
Maryam Rettmann
DPDouglas L. Packer
Douglas L. Packer